Epidemiological characteristics and medical follow-up of 61 patients with acute hepatitis C identified through the hepatitis C surveillance system in France

Epidemiology and Infection

Volumn 136, Issue 7, 2008, Pages 988-996

  Brouard, C ^a,b   Pradat, P ^c,d,e   Delarocque Astagneau, E ^a   Silvain, C ^f  

^a INSTITUT DE VEILLE SANITAIRE   (France)

^b InVS   (France)

^c HÔTEL DIEU   (France)

^d INSERM   (France)

^e UNIVERSITÉ LYON 1   (France)

^f Federation Nationale des Poles de Reference et Reseaux Hepatites   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ACUTE HEPATITIS; ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SURVEILLANCE; EPIDEMIOLOGICAL DATA; FEMALE; FOLLOW UP; FRANCE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; RETROSPECTIVE STUDY; SEROCONVERSION; SEX RATIO; VIRUS TRANSMISSION;

ADULT; AGED; FEMALE; FRANCE; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; RNA, VIRAL; SEROLOGIC TESTS; SUBSTANCE-RELATED DISORDERS; SURGICAL PROCEDURES, OPERATIVE;

EID: 44049093364     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268807009417     Document Type: Article

References (38)

1. Hofer H, et al. Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load. Hepatology 2003; 37: 60-64.
2. Alter MJ, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. New England Journal of Medicine 1992; 327: 1899-1905.
3. Hoofnagle JH. Course and outcome of hepatitis C. Hepatology 2002; 36: S21-S29.
4. Nomura H, et al. Short-term interferon-alfa therapy for acute hepatitis C: A randomized controlled trial. Hepatology 2004; 39: 1213-1219.
5. Wedemeyer H, et al. Whom? When? How? Another piece of evidence for early treatment of acute hepatitis C. Hepatology 2004; 39: 1201-1203.
6. Craxi A, Licata A. Acute hepatitis C: In search of the optimal approach to cure. Hepatology 2006; 43: 221-224.
7. Robotin MC, et al. Surveillance for newly acquired hepatitis C in Australia. Journal of Gastroenterology and Hepatology 2004; 19: 283-288.
8. Jaeckel E, et al. Treatment of acute hepatitis C with interferon alfa-2b. New England Journal of Medicine 2001; 345 1452-1457.
9. Morin T, Pariente A. Acute hepatitis C: A retrospective study of 62 cases. Gastroenterologie Clinique et Biologique 2002; 26: 994-1000.
10. Rocca P, et al. Early treatment of acute hepatitis C with interferon alpha-2b or interferon alpha-2b plus ribavirin: Study of sixteen patients. Gastroenterologie Clinique et Biologique 2003; 27: 294-299.
11. Morin T. National observatory of acute hepatitis C: Preliminary results. Gastroenterologie Clinique et Biologique 2005; 29 (Suppl.): 1225.
12. Jauffrot-Roustide M, et al. Assessment of HIV and HCV seroprevalence and drug-users profiles: InVS-ANRS Coquelicot Study, France, 2004. Bulletin Epidémiologique Hebdomadaire 2006; 33 244-247.
13. Martinez-Bauer E, et al. Hospital admission is the only epidemiological risk factor in most cases of acute hepatitis C. Journal of Hepatology 2006; 44 (Suppl. 2): S201-S201.
14. Wu HX, et al. Enhanced surveillance of newly acquired hepatitis C virus infection in Canada, 1998 to 2004. Scandinavian Journal of Infectious Diseases 2006; 38: 482-489.
15. Delarocque-Astagneau E, et al. Outbreak of hepatitis C virus infection in a hemodialysis unit: Potential transmission by the hemodialysis machine? Infection Control and Hospital Epidemiology 2002; 23: 328-334.
16. Germain JM, et al. Patient-to-patient transmission of hepatitis C virus through the use of multidose vials during general anesthesia. Infection Control and Hospital Epidemiology 2005; 26: 789-792.
17. Bronowicki JP, et al. Patient-to-patient transmission of hepatitis C virus during colonoscopy. New England Journal of Medicine 1997; 337: 237-240.
18. Desenclos JC, et al. Hepatitis C in a ward for cystic fibrosis and diabetic patients: Possible transmission by spring-loaded finger-stick devices for self-monitoring of capillary blood glucose. Infection Control and Hospital Epidemiology 2001; 22: 701-707.
19. Delarocque-Astagneau E, et al. Modes of hepatitis C virus transmission: Methodological approaches. Revue d'Epidemiologie et de Sante Publique 2006; 54 (Suppl. 1): 1S5-1S14.
20. Mele A, et al. Risk of parenterally transmitted hepatitis following exposure to surgery or other invasive prdoedures: Results from the hepatitis surveillance system in Italy. Journal of Hepatology 2001; 35: 284-289.
21. Ciando A, et al. Digestive endoscopy is not a major risk factor for transmitting hepatitis C virus. Annals of Internal Medicine 2005; 142: 903-909.
22. Alter MJ. Hepatitis C virus infection in the United States. Journal of Hepatology 1994; 31 (Suppl. 1): 88-91.
23. Alter MJ, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. New England Journal of Medicine 1999; 341: 556-562.
24. Mele A, et al. Heterosexual transmission of hepatitis C in Italy. Journal of Medical Virology 1999; 57: 111-113.
25. Balasekaran R, et al. A case-control study of risk factors for sporadic hepatitis C virus infection in the southwestern United States. American Journal of Gastroenterology 1999; 94: 1341-1346.
26. Murphy EL, et al. Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS). Hepatology 2000; 31: 756-762.
27. Vandelli C, et al. Lack of evidence of sexual transmission of hepatitis C among monogamous couples: Results of a 10-year prospective follow-up study. American Journal of Gastroenterology 2004; 99: 855-859.
28. Gambotti L, et al. Acute hepatitis C infection in HIV positive men who have sex with men in Paris, France, 2001-2004. Eurosurveillance 2005; 10: 115-117.
29. Ghosn J, Leruez-Ville M, Chaix ML. Sexual transmission of hepatitis C virus. Presse Medicale 2005; 34: 1034-1038.
30. Paryan C, et al. Changing of hepatitis C virus genotype patterng in France at the beginning of the third millenium: The GEMHEP GenoCII Study. Journal of Viral Hepatitis 2005; 12: 405-413.
31. Delaroeque-Astagneau E, Pioche C, Campese C. National hepatitis C surveillance system based on hepatology reference centres: 2000-2003. National surveillance of infectious diseases, 2001-2003. Saint-Maurice: Institut de veille sanitaire, 2005.
32. Castera L, et al. Hepatitis C virus genotype 4: Epidemiology and treatment. Gastroenterologie Clinique et Biologique 2003; 27: 596-604.
33. Orland JR, Wright TL, Cooper S. Acute hepatitis C. Hepatology 2001; 33: 321-327.
34. Gerlach JT, et al. Acute hepatitis C: High rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 2003; 125: 80-88.
35. Villano SA, et al. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology 1999; 29: 908-914.
36. Larghi A, et al. Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies. Hepatology 2002; 36: 993-1000.
37. Santantonio T, et al. Natural course of acute hepatitis C: A long-term prospective study. Digestive Liver Disease 2003; 35 104-113.
38. Lerebours E, Marcellin P, Dhumeaux D. Treatment of hepatitis C: advances and consensus. Gastroenterologie Clinique et Biologique 2002; 26 (Special No. 2,): B5-B6.